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Objective: To identify rule sets based on administrative data to detect the IOM priority 
conditions (Persistent Asthma, Diabetes, Heart Failure, COPD, Hypertension, MI, Stroke, 
& Hyperlipidemia) as well as obesity and depression, and also to evaluate each rule set's 
applicability to clinical decision support (CDS) 
Design: Administrative Code based rule sets generated by an iterative process and 
evaluated by direct comparison with a chart review based gold standard. 
Data sources: Medicaid claims data from North Carolina Health Information Exchange 
compared with electronic medical records from the Duke University Health System. 
Results: 10 diseases were included in our study.  Of these 10, only 2 diseases, 
hypertension (HTN) and diabetes mellitus (DM) produced adequate rule sets for clinical 
decision support.  HTN had PPVs ranging from 0.89 to 0.94, and DM had PPVs ranging 
from 0.91 to 0.94.  The rule sets for the other diseases all had PPVs less then 0.90, and 
were thus not considered to be useful for clinical decision support.  Because not everyone 
using disease detection algorithms has a CDS focus, we have included the performance of 
all our generated rule-sets in tabular format. 
Conclusions: Several factors were closely correlated with a rule set’s ability to accurately 
detect the presence of a particular disease.  Perhaps the greatest of these factors was the 
granularity of the underlying code system.  For the 2 diseases which had very specific 
ICD codes (i.e. HTN and DM), a simple and accurate rule set was created. 
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Introduction 
Evaluating Rule Sets for Clinical Decision Support 
In this study, the authors evaluated candidate rule sets for 10 chronic diseases and sought 
to determine which diseases could be accurately detected using only healthcare related 
administrative data.  Our chief purpose was to determine if our candidate rule sets could 
be used for clinical decision support (CDS), and thus we sought to optimize each rule 
set’s positive predictive value.  However, we did document non-CDS related statistical 
measures such as the negative predicative value, sensitivity, specificity, and Youden’s 
index so that our results might be extended to non-CDS applications 
 
Background for Clinical Evaluation and Transparency 
As the evaluation of health care becomes more and more of a topic of public concern, 
improved measures will be necessary to evaluate which patients have a particular illness 
based on information that is readily available and in an electronic format.  Numerous 
articles, including the Institute of Medicine’s (IOM) report, Crossing the Quality 
Chasm(IOM), have discussed the fact that clinical performance measurement systems 
will need to be created if we are to mitigate the inefficiency that currently plagues our 
healthcare system.  To facilitate this quality improvement plan, President George W. 
Bush issued an executive order called the Physician Quality Reporting Initiative (PQRI), 
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which created an impetus for healthcare transparency at all levels of the healthcare 
system (Health and Human).  As a result of this initiative, a number of regional “data 
partnerships” were initiated between private and public health plans for the purpose of 
evaluating our healthcare system.  One such system, the North Carolina Health 
Information Exchange (NCHIE), has enabled multiple patient care interventions to 
improve the care that Medicaid beneficiaries receive in central North Carolina (Lobach et 
al.; M. Schatz and D). 
 
What Information is Being Shared and How It is Used  
Despite the success of systems like NCHIE, most health systems throughout the US do 
not keep medical records in an electronic format, and thus at best only have access to 
“administrative data” (a.k.a. claims data).  The data released by the PQRI is no different, 
and thus the majority of our nation’s healthcare systems can only be evaluated by chart 
review or administrative data review.  Chart review is a laborious and unfeasible method 
to carry out on a large scale, which realistically leaves us with administrative data review 
as the sole option for large-scale healthcare evaluation.  Administrative data primarily 
consists of the codes that are generated whenever a patient is given a diagnosis (ICD-9/10 
or International Classification of Disease),  undergoes a medical procedure (CPT & 
HCPCS for Current Procedural  Terminology & Health Care Financing Agency Common 
Procedure Coding System), or receives a pharmaceutical product (NDC or National Drug 
Code) (NCQA).  Research shows that current methods used to evaluate “administrative 
data” (i.e. without chart review) to determine whether a physician or healthcare system is 
treating a patient according to current standards of care and to determine which patients 
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have certain illnesses are only effective at a suboptimal level (Pawlson, Scholle and 
Powers).   One of these evaluation methods, which is known as the Healthcare 
Effectiveness Data Information Set (HEDIS), was developed by the National Committee 
for Quality Assurance’s (NCQA) Committee on Performance Measurement (NCQA; 
Treadwell and Treadwell).  This NCQA committee does not publish their methods for 
deriving the HEDIS healthcare measures, but does sell the finished algorithms in its 
volume 2 specification manual.  With these finished algorithms, a commercial health 
plan’s performance can be rated and compared with other commercial and government 
health plans (i.e. Medicare/Medicaid and VA)(Pawlson, Scholle and Powers; N. M. 
Mencke and J; Landon et al.).  
 
Advantages and Disadvantages of HEDIS 
Although research demonstrates that patients under managed care organizations (MCO) 
with higher HEDIS scores tend to have reduced healthcare costs and improved disease 
management, the criterion HEDIS uses to determine which patients have a certain disease 
has been shown to lack sensitivity and specificity when compared with national 
guidelines and chart review (Sidorov et al.; Cabana et al.; Mainous and Talbert). 
However, this does not mean that HEDIS, or similar rule-sets, are not currently being 
implemented.  HEDIS is one of only a few administrative data toolsets that US healthcare 
currently has to evaluate itself, and thus many organizations continue to use its metrics 
for lack of a better alternative. 
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HEDIS’ Applicability to Clinical Informatics 
Currently, there is a push outside of the managed care industry to find ways of using 
healthcare administrative data to improve patient care at the hospital and primary care 
levels.  The hope is that the use of shared administrative data will allow primary care 
physicians and managed care coordinators to better utilize information technology.  Such 
information will provide better tools to determine which patients will likely need 
increased attention, which patients are not adhering to medical advice, and which patients 
are not being treated according to current standards of care.  In essence, this 
administrative data can be utilized to better inform the healthcare providers instead of 
being used only by the healthcare payers (e.g. insurance agencies).  A number of tools to 
accomplish this task have already been created and implemented, and they continue to 
impact communities such as Durham, NC (Eisenstein et al.).  However, continued 
improvement and refinement of these clinical informatics tools is still needed. The 
standards currently being employed to guide these informatics tools, like HEDIS, still 
need to be rigorously scrutinized and evaluated to determine if these standards can be 
optimized further before they are applied in clinical informatics areas such as pay for 
performance or decision support. 
 
Creating Standard Rule Sets to Detect Disease from Administrative Data 
Many authors have developed algorithms to increase the specificity and sensitivity of 
detecting diseases from administrative codes (Solberg et al.; Bullano et al.; Wakefield 
and Cloutier).  These improved algorithms (when compared to HEDIS) primarily focus 
on hypertension, diabetes mellitus and depression.  However, there are many diseases 
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that these improved algorithms do not address, and consequently many diseases do not 
have an optimized administrative code detection algorithm.  This study aimed at 
generating improved detection algorithms for all of the IOM’s eight priority conditions 
(persistent asthma, diabetes, heart failure, COPD, hypertension, MI, stroke, & 
hyperlipidemia)(Adams and Corrigan) with the addition of obesity and depression.  
Additionally, we sought to determine if the improved rule sets found in literature applied 
to the North Carolina Piedmont Medicaid population. 
 
Clinical Decision Support (CDS) Systems and Administrative Code Optimization 
CDS systems rely on accurate information reaching the care provider in a timely and 
workflow inclusive manor (Kawamoto et al.).  Additionally, delivering accurate 
recommendations to the care provider with the minimum number of false positives is 
extremely important to any CDS system’s utility (Solberg et al.).  To assess the ability of 
a particular rule/criteria to accurately predict the presence of a disease, a positive 
predictive value (PPV) is normally used.  “PPV is defined as the proportion of patients 
with positive test results who are correctly diagnosed.  It also is the most important 
measure of a diagnostic method as it reflects the probability that a positive test reflects 
the underlying condition being tested for (Contributors).”  It can be calculated using the 
equation: 
TP/(FP+TP) 
Where TP= true positives and FP = false positives 
Similarly, a negative predictive value (NPV) can be calculated using the equation: 
FN/(FN+TN) 
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Where FN= false negatives and TN= true negatives 
NPV is often used to evaluate a test’s ability to predict the absence of a disease (i.e. rule-
out a disease).  Also, a value known as Youden’s index (Sensitivity + Specificity -1) is 
often used as a measure of overall rule performance since this value takes into account a 
rule’s overall ability to predict the presence or absence of a disease.  (note: a Youden’s 
index of 1 implies perfect PPV and NPV, while an index of -1 implies a poorly 
performing rule/test)(Wakefield and Cloutier).   Because this study was aimed at 
improving an administrative code based rule/test’s ability to accurately predict the 
presence of disease, optimizing a disease detection algorithm’s PPV was of central 
importance, however, we included all of the above mentioned statistical values in the 
hope that our results might be extended to non-CDS applications as well.   
 
NCHIE to Evaluate and Generate Improved Disease Detection Code Sets 
Research for this study utilized a regional Health Information Exchange (HIE) network 
created to connect providers serving 37,000 Medicaid beneficiaries across traditional 
institutional boundaries from both rural and urban settings in a 5 county region in the 
Northern Piedmont of North Carolina. Using this HIE, we were able to select only those 
beneficiaries’ administrative codes for which a corresponding accurate and complete 
medical record could be obtained.  These patient records were then used to evaluate the 
accuracy of various code based disease detection algorithms in an iterative manner.   
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Methods 
Methods Overview 
This study was broken down into four main parts. The first part involved writing a 
java/SQL filter to select only patients from the underlying claims database (a.k.a. 
COACH) that met our inclusion criteria (See Figure 1).  Following this step, a chart 
review was conducted to record which studied disease(s) were present in each of the 
selected patients.   Next, a java and SQL based computer program was created to retrieve 
each patient’s administrative codes that represented a specific disease studied by our 
group.  Finally, a comparison was made between these code counts and the chart review 
generated gold standard.   
 
Patient Record Selection 
Data was analyzed from 11/04, or 11/06, to 11/08 depending on the rule criteria.   Each 
patient included in this study had to be continuously enrolled in Medicaid during our 
evaluation period.  Continuous enrollment was determined by counting each patient’s 
enrollment records per year and ensuring that this value was greater then or equal to 10.   
We then analyzed this patient record set and selected only those patients for whom we 
had complete access to their electronic medical record.  In addition, we required that their 
patient records indicate that their primary care provider was affiliated with the Duke 
University Health System.  The resulting records were then randomized and reviewed for 
inclusion into our gold standard set. 
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Chart Review and Filtering Criteria 
In order to critically evaluate the accuracy of each code based disease detection 
algorithm, a “gold standard” tuple of each patient’s clinically diagnosed disease(s) paired 
with their unique identifier was generated.  To determine which patients qualified as 
having a particular disease of interest, a chart review of all non-filtered COACH records 
was conducted (See Figure 1). These chart audits were done by a 4th year medical 
student with the oversight and guidance of senior physicians from the Duke Department 
of Community and Family Medicine.     
This audit consisted of: 
1. Observing each patient's last 4 records, or last 2 years of records (whichever 
comes first), generated by an internal or primary care physician (PCP or 
generalist).   
a. A physician was considered a PCP if they served as a particular 
patient's primary care physician (i.e. the physician was treating, and or 
monitoring, a patient's health maintenance), and the physician had 
training in an internal/family medicine residency to acquire their 
practicing license.  This choice was made due to the observation 
during initial chart audits that Duke Family Medicine, Duke 
Outpatient, and Duke General Medicine notes included the most 
comprehensive medical records available to the auditor.   
b. We found that 96% of IOM diseases of interest were found by 
reviewing the 4 most recent PCP patient records, and 100% of patient 
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diagnoses were found by reviewing a patient's past 2 years of medical 
records. 
2. Observing all acute care records occurring after the latest PCP’s note. 
a. The authors decided to review these recent acute care records to ensure 
that a diagnoses coded after the most recent PCP note would not be 
missed by our audit (e.g. a myocardial infarction emergency room 
record for a patient who had not had not yet had a follow-up 
appointment with their PCP would have produced an erroneous gold 
standard result if we had not included this criteria).  
3. Manually observing each record's problem list to determine if a particular 
IOM disease was/is present based on clinical evaluation. 
4. Observing the assessment and plan sections of each record for keywords 
either synonymous with a studied disease, or descriptive of a studied disease. 
If any of the above audit steps resulted in the identification of a particular IOM disease of 
interest, the patient chart's unique identifier was added to the respective disease list (i.e. if 
a patient was found to have diabetes mellitus (DM) they were added to the DM list). 
Also, if the record represented a patient with DM, then an effort was made to determine 
whether the patient had type 1 or type 2 DM, and this delineation was recorded. This 
process was repeated for the four most recent PCP notes, or 2 years of patient records, 
whichever came first. If multiple IOM diseases were found in a patient's chart, the 
patient's unique identifier would be added to multiple IOM disease lists. 
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Results 
While others have developed similar disease detection rules, most authors optimize their 
rule sets for the greatest combination of specificity and sensitivity.  Since our aim was to 
use our rule sets for clinical decision support, it was our hope to generate algorithms that 
were optimized for the highest possible PPV while still maintaining adequate sensitivity.  
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Below are the results for each of the diseases studied, as well as background information 
for each algorithm’s developmental process.  
 
Diabetes Mellitus (DM) 
Diabetes Mellitus is perhaps the most studied and most optimized of any of the IOM 
diseases we studied (Solberg et al.).  Given the high prevalence of DM in our population 
(137/601, 22.8%), it was much easier to achieve statistical significance and develop 
relevant results. The detection of DM from administrative codes has already been 
extensively studied by HEDIS (Solberg et al.), and the result of using HEDIS’ published 
DM rule (without drug codes) on our patient population is presented in table 1.  For CDS, 
HEDIS’ criteria performed almost identically to all of the other rule sets we generated. 
(See Table 1) 
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Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
4 years historical data with greater 
then or equal to 1 outpatient  OR 
greater then or equal to 1 inpatient 
250%, 357% or 362% codes 
 
0.97 0.97 0.91 0.99 0.94 
4 years historical data with greater 
then or equal to 2 outpatient OR 
greater then or equal to1 inpatient 
250%, 357% or 362% codes 
 
0.98 0.94 0.92 0.98 0.92 
4 years historical data with greater 
then or equal to 3 outpatient OR 
greater then or equal to1 inpatient 
250%, 357% or 362% codes 
 
0.98 0.93 0.92 0.98 0.91 
 2 years historical data with greater 
then or equal to1 outpatient OR 
greater then or equal to1 inpatient 
250%, 357% or 362% code (note: 
HEDIS criteria) 
 
0.98 0.93 0.93 0.98 0.91 
2 years historical data with greater 
then or equal to 2 outpatient OR 
greater then or equal to1 inpatient 
250%, 357% or 362% codes 
 
0.98 0.90 0.94 0.97 0.88 
2 years historical data with greater 
then or equal to 3 outpatient OR 
greater then or equal to1 inpatient 
250%, 357% or 362% codes 
0.98 0.85 0.94 0.96 0.84 
Table 1: Diabetes -- Sensitivity, Specificity and Predictive Values of Algorithms to Identify 
Probable Diabetes in the Medicaid Study Group 
 
Myocardial Infarction (MI) 
MI was much more difficult to detect with administrative codes alone.  These authors 
were unable to find one reliable code set in literature, but did notice multiple chart review 
or hybrid based algorithms (e.g. HEDIS).  Given the low prevalence in our patient cohort 
(25/601, 4%), our statistical significance is low.  Our detection code set was based on the 
clinical classification software disease bundle for myocardial ischemia (Research), and it 
is important to note that adding the additional criteria of “previous coronary artery bypass 
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graft (CABG)” did not improve our results (it is included here only for documentation 
purposes). (See Table 2) 
 
Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
Greater then or equal to 1 inpatient 
410.% code diagnosis in the past 4 
years (note: HEDIS criteria) 
 
0.99 0.24 0.67 0.97 0.23 
Greater then or equal to 1 inpatient 
410.% code diagnosis or CABG in the 
past 4 years 
 
0.99 0.24 0.67 0.97 0.23 
Greater then or equal to 2 inpatient 
410.% code diagnosis or CABG in the 
past 4 years 
0.99 0.24 0.67 0.97 0.23 
Greater then or equal to 3 inpatient 
410.% code diagnosis or CABG in the 
past 4 years 
 
1.00 0.20 0.71 0.97 0.20 
Greater then or equal to 1 inpatient 
410.% code diagnosis or CABG in the 
past 2 years 
 
0.99 0.20 0.63 0.97 0.19 
Greater then or equal to 2 inpatient 
410.% codes diagnosis or CABG in 
the past 2 years 
 
0.99 0.20 0.63 0.97 0.19 
greater then or equal to 3 inpatient 
410.% codes diagnosis or CABG in 
the past 2 years 
1.00 0.12 0.60 0.96 0.12 
Table 2: Myocardial Infarction -- Sensitivity, Specificity and Predictive Values of 
Algorithms to Identify Probable Myocardial Infarction in the Medicaid Study Group 
 
Hypertension (HTN) 
Hypertension, like DM, was extremely prevalent in our patient population (294/601, 
48.9%) and thus our statistical significance was adequate to make accurate evaluations of 
our generated rules.  There have been many articles published on developing 
hypertension code based detection algorithms (Tang et al.; Caetano, Lam and Morgan), 
and each performs well and is comparable to our rule sets.  Virtually all of these 
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algorithms did not include drug data in their final HTN code based detection algorithm. 
(See Table 3) 
 
Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
Greater then or equal to 1 outpatient 
encounter with diagnosis 401.*, 402, 403, 
404, OR 405 code in the past 4 years  
 
0.90 0.95 0.89 0.95 0.84 
Greater then or equal to 2 outpatient 
encounters with diagnosis 401.*, 402, 
403, 404, OR 405 code in the past 4 
years  
 
0.93 0.87 0.92 0.88 0.81 
 Greater then or equal to 3 outpatient 
encounters with diagnosis 401.*, 402, 
403, 404, OR 405 code in the past 4 
years  
 
0.95 0.80 0.94 0.83 0.75 
 Greater then or equal to 1 outpatient 
encounter with diagnosis 401.*, 402, 403, 
404, OR 405 code in the past 2 years  
 
0.91 0.90 0.90 0.91 0.81 
 Greater then or equal to 2 outpatient 
encounters with diagnosis 401.*, 402, 
403, 404, OR 405 code in the past 2 
years  
 
0.94 0.80 0.93 0.83 0.74 
Greater then or equal to 3 outpatient 
encounters with diagnosis 401.*, 402, 
403, 404, OR 405 code in the past 2 
years  
0.95 0.70 0.94 0.76 0.65 
Table 3: Hypertension -- Sensitivity, Specificity and Predictive Values of Algorithms to 
Identify Probable Hypertension in the Medicaid Study Group 
 
Cerebral Ischemia (Stroke) 
The prevalence of Cerebral Ischemia in this population was extremely small (21/601, 
3.5%) thus the significance of our results is questionable. However some insight can still 
be gained from our findings.  We noticed that strokes are very frequently coded 
incorrectly (17 of our 21 chart review positive patients did not have a single stroke code), 
and many of these false negative patients did have a transient ischemia attack (TIA) code 
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(75%).  After trying many variations of the AHRQ set (see bottom of Table 4), we found 
no benefit (i.e. increased PPV) to eliminating any of the AHRQ codes from the bundle 
(Research).  (See Table 4) 
 
Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
Greater then or equal to 1 inpatient 
AHRQ* acute cerebral vascular disease 
diagnosis code in the past 4 years 
 
0.99 0.19 0.57 0.97 0.19 
Greater then or equal to 2 inpatient 
AHRQ* acute cerebral vascular disease 
diagnosis codes in the past 4 years 
 
1.00 0.14 0.75 0.97 0.14 
Greater then or equal to 3 inpatient 
AHRQ* acute cerebral vascular disease 
diagnosis codes in the past 4 years 
 
1.00 0.05 1.00 0.97 0.05 
Greater then or equal to 1 inpatient 
AHRQ* acute cerebral vascular disease 
diagnosis code in the past 2 years 
 
1.00 0.19 0.67 0.97 0.19 
Greater then or equal to 2 inpatient 
AHRQ* acute cerebral vascular disease 
diagnosis codes in the past 2 years 
 
1.00 0.09 1.00 0.97 0.09 
Greater then or equal to 3 inpatient 
AHRQ* acute cerebral vascular disease 
diagnosis codes in the past 2 years 
1.00 0.05 1.00 0.97 0.05 
Table 4: Cerebral Ischemia (Stroke) --Sensitivity, Specificity and Predictive Values of 
Algorithms to Identify Probable Cerebral Ischemia in the Medicaid Study Group 
*AHRQ acute cerebral disease codes: '346.60', '346.61', '346.62', '346.63',  '433.01', '433.11', 
'433.21', '433.31', '433.81', '433.91', '434.0', '434.00', '434.01', '434.1', '434.10',  '434.11', 
'434.9', '434.90', '434.91','433.10' 
 
Obesity  
Obesity as defined as a body mass index >25 was extremely prevalent in our studied 
patient population (183/601, 30%), but unlike DM and HTN, which also had a high 
prevalence, there were very few codes available to detect this disease, and thus the 
performance of our obesity rule sets was suboptimal for CDS. (See Table 5)   
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Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
Greater then or equal to 1 diagnosis 
V85.2-5 or 278% code(s) in the past 4 
years 
 
0.87 0.61 0.67 0.84 0.48 
Greater then or equal to 2 diagnosis 
V85.2-5 or 278% code(s) in the past 4 
years 
 
0.93 0.44 0.72 0.79 0.36 
Greater then or equal to 3 diagnosis 
V85.2-5 or 278% code(s) in the past 4 
years 
 
0.95 0.34 0.74 0.77 0.29 
Greater then or equal to1 diagnosis 
V85.2-5 or 278% code(s) in the past 2 
years 
 
0.90 0.47 0.67 0.79 0.37 
Greater then or equal to 2 diagnosis 
V85.2-5 or 278% code(s) in the past 2 
years 
 
0.94 0.33 0.73 0.76 0.28 
Greater then or equal to 3 diagnosis 
V85.2-5 or 278% code(s) in the past 2 
years 
0.96 0.25 0.75 0.75 0.22 
Table 5: Obesity --Sensitivity, Specificity and Predictive Values of Algorithms to Identify 
Probable Obesity in the Medicaid Study Group 
 
Hyperlipidemia (HLD) (see Table 6) 
HLD was similar to obesity in that it had a high prevalence (163/601, 27%) but lacked 
adequate positive predicative value (PPV).  The code sets used for this algorithm were 
derived from an AHRQ bundle and a list of NDC codes corresponding to 
antihyperlipidemic class drugs.  Of note: adding the HLD drug criteria did little to 
improve the PPV. (See Table 6) 
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Criteria Used Sensitivity Specificity PPV NPV 
Youden'
s Index 
Greater then or equal to 1  272.% 
outpatient codes OR greater then or 
equal to 1 HLD drug in past 4 years 
 
0.91 0.82 0.77 0.93 0.73 
Greater then or equal to 2 272.% 
outpatient codes OR greater then or 
equal to 1 HLD drug in past 4 years 
 
0.91 0.79 0.77 0.92 0.70 
Greater then or equal to 3 272.% 
outpatient codes OR greater then or 
equal to 1 HLD drug in past 4 years 
 
0.91 0.75 0.76 0.91 0.67 
Greater then or equal to 1  272.% 
outpatient codes OR greater then or 
equal to 1 HLD drug in past 2 years 
 
0.91 0.81 0.78 0.93 0.72 
Greater then or equal to 2 272.% 
outpatient codes OR greater then or 
equal to 1 HLD drug  in past 2 years 
 
0.91 0.78 0.77 0.92 0.69 
Greater then or equal to 3 272.% 
outpatient codes OR greater then or 
equal to 1 HLD drug in past 2 years 
 
0.91 0.75 0.76 0.91 0.67 
Greater then or equal to 1  272.% 
outpatient codes OR greater then or 
equal to 2 0.72HLD drug in past 4 years 
 
0.91 0.82 0.77 0.93 0.73 
Greater then or equal to 2 272.% 
outpatient codes OR greater then or 
equal to 2 HLD drug in past 4 years 
 
0.91 0.80 0.77 0.92 0.71 
Greater then or equal to 3 272.% 
outpatient codes OR greater then or 
equal to 2 HLD drug in past 4 years 
 
0.91 0.75 0.76 0.91 0.67 
Greater then or equal to 1 272.% 
outpatient codes OR greater then or 
equal to 2 HLD drug in past 2 years 
 
0.91 0.81 0.78 0.93 0.72 
Greater then or equal to 2 272.% 
outpatient codes OR greater then or 
equal to 2 HLD drug in past 2 years 
 
0.91 0.78 0.77 0.92 0.69 
Greater then or equal to 3 272.% 
outpatient codes OR greater then or 
equal to 2 HLD drug in past 2 years 
 
0.91 0.75 0.76 0.91 0.67 
Greater then or equal to 1 272.% 
outpatient codes OR greater then or 
equal to 3 HLD drug in past 4 years 
 
0.91 0.82 0.77 0.93 0.73 
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Greater then or equal to 2 272.% 
outpatient codes OR greater then or 
equal to 3 HLD drug in past 4 years 
 
0.91 0.80 0.77 0.92 0.71 
Greater then or equal to 3 272.% 
outpatient codes OR greater then or 
equal to 3 HLD drug in past 4 years 
 
0.91 0.75 0.76 0.91 0.67 
Greater then or equal to 1 272.% 
outpatient codes OR greater then or 
equal to 3 HLD drug in past 2 years 
 
0.91 0.81 0.78 0.93 0.72 
Table 6: Hyperlipidemia --Sensitivity, Specificity and Predictive Values of Algorithms to 
Identify Probable Hyperlipidemia in the Medicaid Study Group 
 
Depression 
Depression had a fairly high prevalence (175/601, 29%) in our evaluated population, but 
like obesity and hyperlipidemia, none of our algorithms produced significant PPVs for 
CDS.  This may have been due to our decision not to use drug-based codes in our final 
algorithms.  However, other groups have shown that including drug information would 
most likely result in increased false positives (antidepressants currently have low 
specificity for depression) and thus a decreased PPV (Solberg et al.).  (See Table 7) 
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Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
292.2%, 266.3%, 300.4% or 311% 
with 1 or more outpatient or at least 1 
inpatient in last 4 years 
 
0.92 0.47 0.71 0.81 0.39 
 292.2%, 266.3%, 300.4% or 311% 
with 1 or more outpatient or at least 2 
inpatient in last 4 years 
 
0.94 0.43 0.74 0.80 0.37 
 292.2%, 266.3%, 300.4% or 311% 
with 2 or more outpatient or at least 1 
inpatient in last 4 years 
 
0.95 0.36 0.75 0.78 0.31 
 292.2%, 266.3%, 300.4% or 311% 
with 2 or more outpatient or at least 2 
inpatient in last 4 years 
 
0.97 0.30 0.79 0.77 0.26 
 292.2%, 266.3%, 300.4% or 311% 
with 3 or more outpatient or at least 1 
inpatient in last 4 years 
 
0.96 0.33 0.76 0.78 0.28 
 292.2%, 266.3%, 300.4% or 311% 
with 3 or more outpatient or at least 2 
inpatient in last 4 years 
 
0.98 0.26 0.82 0.76 0.23 
 292.2%, 266.3%, 300.4% or 311% 
with 1 or more outpatient or at least 1 
inpatient in last 2 years 
 
0.94 0.38 0.73 0.79 0.32 
 292.2%, 266.3%, 300.4% or 311% 
with 1 or more outpatient or at least 2 
inpatient in last 2 years 
 
0.95 0.31 0.71 0.77 0.26 
 292.2%, 266.3%, 300.4% or 311% 
with 2 or more outpatient or at least 1 
inpatient in last 2 years 
 
0.96 0.28 0.77 0.77 0.24 
 292.2%, 266.3%, 300.4% or 311% 
with 2 or more outpatient or at least 2 
inpatient in last 2 years 
 
0.97 0.21 0.76 0.75 0.18 
 292.2%, 266.3%, 300.4% or 311% 
with 3 or more outpatient or at least 1 
inpatient in last 2 years 
 
0.98 0.26 0.82 0.76 0.23 
 292.2%, 266.3%, 300.4% or 311% 
with 3 or more outpatient or at least 2 
inpatient in last 2 years 
0.98 0.17 0.81 0.74 0.15 
Table 7: Depression --Sensitivity, Specificity and Predictive Values of Algorithms to 
Identify Probable Depression in the Medicaid Study Group 
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Congestive Heart Failure (CHF)  
CHF, like MI, suffered from low representation in our population under study (17/601), 
and also like MI, it lacked adequate code granularity to accurately detect the disease’s 
presence in our patient population. (See Table 8).  The PPV range was 0.30 to 0.57, and 
thus none of our rule sets should be used for CDS. 
 
Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
Greater then or equal to1   428.% 
encounters in past 4 years 
  
0.95 0.71 0.30 0.99 0.66 
Greater then or equal to2   428.% 
encounters in past 4 years  
 
0.97 0.71 0.40 0.99 0.68 
Greater then or equal to3  428.% 
encounters in past 4 years  
 
0.98 0.71 0.50 0.99 0.69 
Greater then or equal to4  428.% 
encounters in past 4 years  
 
0.98 0.59 0.48 0.99 0.57 
Greater then or equal to5  428.% 
encounters in past 4 years  
 
0.98 0.59 0.48 0.99 0.57 
Greater then or equal to1   428.% 
encounters in past 2 years  
 
0.97 0.65 0.39 0.99 0.62 
Greater then or equal to2   428.% 
encounters in past 2 years  
 
0.98 0.53 0.41 0.99 0.51 
Greater then or equal to3  428.% 
encounters in past 2 years  
 
0.99 0.47 0.50 0.98 0.46 
Greater then or equal to4  428.% 
encounters in past 2 years  
 
0.99 0.47 0.53 0.98 0.46 
Greater then or equal to5  428.% 
encounters in past 2 years  
 
0.99 0.47 0.57 0.98 0.46 
Table 8: Congestive Heart Failure --Sensitivity, Specificity and Predictive Values of 
Algorithms to Identify Probable Congestive Heart Failure in the Medicaid Study Group 
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Chronic Obstructive Pulmonary Disease (COPD) 
COPD prevalence in our population under study was only 4% (28/601).  The PPV’s were 
similar throughout our entire rule set iterations, and with a max PPV of 64%, it is 
unlikely that a purely code based algorithm could be used effectively in a COPD CDS 
system.  Also of note: we decided not to use drug codes because of the overlap between 
asthma and COPD medications in adult populations. 
 
Criteria Used Sensitivity Specificity PPV NPV 
Youden's 
Index 
Greater then or equal to 1  493.2%, or 
496% diagnoses in 4 year history 
 
0.95 0.86 0.46 0.99 0.81 
Greater then or equal to 2  493.2% or 
496% diagnoses in 4 years history 
 
0.97 0.82 0.56 0.99 0.79 
Greater then or equal to 3  493.2% or 
496% diagnoses in 4 year history 
 
0.98 0.75 0.64 0.99 0.73 
Greater then or equal to 1  493.2% or 
496% diagnoses in 2 year history 
 
0.95 0.86 0.46 0.99 0.81 
Greater then or equal to 2  493.2% or 
496% diagnoses in 2 year history 
 
0.97 0.82 0.56 0.99 0.79 
Greater then or equal to 3  493.2% or 
496% diagnoses in 2 year history 
 
0.98 0.75 0.64 0.99 0.73 
Table 9: Chronic Obstructive Pulmonary Disease (COPD) --Sensitivity, Specificity and 
Predictive Values of Algorithms to Identify COPD in the Medicaid Study Group 
 
Persistent Asthma 
Persistent asthma prevalence in our study population was only 6% (40/601).  The PPVs 
were similar throughout all of our rule set iterations, and with a max PPV of 46%, it is 
unlikely that a purely code based algorithm could be used effectively in a persistent 
asthma CDS system. (See Table 10).  Also of note: we decided not to use drug codes 
because of the overlap between asthma and COPD medications in adult populations.  If 
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we had used a purely pediatric patient population, the drug codes could have been 
included.  Wakefield et. al. included drug codes in a similar pediatric study and found 
that including drug information did improve overall performance (Wakefield and 
Cloutier).  
 
 
Criteria Used 
Sensitivity Specificity PPV NPV Youden's 
Index 
Greater then or equal to 1 inpatient 
493% or greater then or equal to1 
ER/inpatient  493.% encounters in 
past 4 years  
 
0.88 0.78 0.32 0.98 0.66 
Greater then or equal to 1 inpatient 
493% or greater then or equal to 2 
ER/inpatient  493.% encounters in 
past 4 years  
 
0.91 0.78 0.38 0.98 0.69 
Greater then or equal to 2 inpatient 
493% or greater then or equal to 1 
ER/inpatient  493.% encounters in 
past 4 years  
 
0.89 0.73 0.33 0.98 0.62 
Greater then or equal to 2 inpatient 
493% or greater then or equal to 2 
ER/inpatient  493.% encounters in 
past 4 years  
 
0.93 0.70 0.40 0.98 0.63 
Greater then or equal to 3 inpatient 
493% or greater then or equal to 1 
ER/inpatient  493.% encounters in 
past 4 years  
 
0.91 0.70 0.35 0.98 0.61 
Greater then or equal to 3 inpatient 
493% or greater then or equal to 2 
ER/inpatient  493.% encounters in 
past 4 years  
 
0.94 0.68 0.43 0.98 0.61 
Greater then or equal to 1 inpatient 
493% or greater then or equal to 1 
ER/inpatient  493.% encounters in 
past 2 years  
 
0.92 0.70 0.39 0.98 0.62 
Greater then or equal to 1 inpatient 
493% or greater then or equal to 2 
ER/inpatient  493.% encounters in 
past 2 years  
0.94 0.70 0.47 0.98 0.64 
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Greater then or equal to 2 inpatient 
493% or greater then or equal to 1 
ER/inpatient  493.% encounters in 
past 2 years  
 
0.93 0.63 0.38 0.97 0.55 
Greater then or equal to 2 inpatient 
493% or greater then or equal to 2 
ER/inpatient  493.% encounters in 
past 2 years  
 
0.95 0.60 0.46 0.97 0.55 
Greater then or equal to 3 inpatient 
493% or greater then or equal to 1 
ER/inpatient  493.% encounters in 
past 2 years  
 
0.93 0.53 0.35 0.96 0.46 
Greater then or equal to 3 inpatient 
493% or greater then or equal to 2 
ER/inpatient  493.% encounters in 
past 2 years  
 
0.95 0.50 0.43 0.96 0.45 
Table 10: Persistent Asthma--Sensitivity, Specificity and Predictive Values of Algorithms 
to Identify Persistent Asthma in the Medicaid Study Group 
 
Discussion 
 
This study illustrates that although claims data are a convenient way to detect patient 
disease, the accuracy for each code based algorithm is very disease dependent.   Certain 
diseases rule sets such as the hypertension and diabetes rule sets perform well with 
simple and straightforward code based algorithms, while rule sets for diseases like 
obesity, which lacks a defined ICD-9 code set, suffer from extremely poor performance.  
Since current literature tends to contain rule sets for only those diseases that are detected 
accurately from administrative codes, we thought it was important to document the 
performance of rule sets for diseases that do not perform well.  Our hope is that others 
might learn from our experience and make an informed judgment as to whether their 
application can tolerate such performance loses.   
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The fact that only 2 of the 10 conditions studied could be detected accurately from code 
based data implies that 8 of our 10 clinical performance judgments must rely on manual 
patient chart audits by trained health care associates.  As discussed previously, this is not 
a viable option, and more must be done to increase the accuracy of our machine-based 
disease detection methods.  This might be accomplished in a number of ways, namely 
further refinement of these rule sets using machine learning (e.g. support vector 
machine), or more appropriately, adding further granularity to the ICD code set so that 
common chronic conditions can be coded unambiguously.  However, both these 
approaches have their limitations.  The machine based learning technique may produce a 
better rule set for a given data set, but it also may include non-clinically relevant codes in 
its final algorithms.  We decided not to use this approach for this very reason (e.g. a code 
for MI may be related to a code for CHF, but having a MI code doesn’t imply having a 
CHF code and should not be used to definitively detect CHF).  Until recently, we 
believed that increasing the granularity of the current ICD-9 code set would have 
addressed our current detection limitations, but since the newer 10th release of the ICD 
code set has been implemented in other countries, other authors have found that the 10th 
revision’s detection performance is still inadequate for many common diseases (Hude 
Quan).  It is not entirely clear how best to improve our current rule sets, but given that 
DM and HTN both had very specific ICD-9 codes, it may still be a code schema 
granularity issue. 
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Limitations 
Small sample testing may be a feasible and important part of validating administrative 
code based disease detection algorithms, but it is important to recognize that there were 
some significant limitations to our approach.  First, small sample sizes limit the precision 
of our calculated PPV.  One author estimated that it would take about 200 or so randomly 
selected chart audits per disease to achieve a 95% confidence interval around a PPV point 
estimate as narrow as +- 4% to 5% (Solberg et al.).  Given our limited sample set, we 
could have only applied this confidence interval to our HTN cohort.  Additional 
limitations resulting from our small sample set include the over performance of certain 
rules (see cerebral ischemia PPV of 1.00) and the under performance of others.   
 
Conclusions 
Using administrative data to detect patient disease has tremendous potential, but as we 
have shown, certain detection algorithms based solely on administrative codes can have 
large limitations.  CDS applications need to be aware of these limitations before they 
implement an administrative code based disease detection rule.  Also, if a rule set is to be 
used for CDS, it is extremely important that the implemented rule set be optimized for 
PPV and not just for sensitivity and/or specificity.  From our results, we conclude that 
detecting hypertension and diabetes mellitus from administrative codes can be done 
accurately with only administrative codes, but detecting any of the other 8 conditions 
studied using administrative data will be accompanied by serious limitations.  
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Our results also point to the need for greater granularity in our current disease coding 
schemas.  Even though we exhausted all relevant codes for each disease studied, only two 
of the disease rule sets (HTN and DM) possessed adequate PPV’s for CDS.  This 
highlights the need for further development in this area.  Given the current focus on 
personal health records (PHR) and electronic health records (EHR), it seems probable 
that some of these granularity issues might be addressed by XML based records formats 
such as health level 7 (HL-7), which will likely be a part of the next generation EHRs and 
PHRs (Health Level Seven).  If this standard were to become prevalent in U.S. health 
records, this research could be repeated and improved rule sets for CDS could be 
determined and implemented.   The end result of these improved CDS systems would 
undoubtedly be improved patient care.
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